Effects of nicotinic acid on glucose tolerance and glucose incorporation into adipose tissue in hypertriglyceridaemia

References

• Berge K G. Side effects of nicotinic acid in treatment of hypercholesteremia. Geriatrics August, 1961; 416–22
   Web of Science ®Google Scholar
• Gurian H, Aldersberg D. The effect of large doses of nicotinic acid on circulating lipids and carbohydrate tolerance. Am J Med Sci 1959; 237: 12–22
   PubMed Web of Science ®Google Scholar
• Miettinen T A, Taskinen M-R, Pelkonen K, Nikkilä EA. Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid. Acta Med Scand 1969; 186: 247–53
   PubMedGoogle Scholar
• Nikkilä EA, Miettinen T A. Nicotinic acid and gluconeogenesis in man. Metabolic effects of nicotinic acid and its derivatives, KF Gey, LA Carlson. Hans Huber, Bern 1971; 753–5
   Google Scholar
• Carlson L A, Eriksson I, Walldius G. A case of massive hypertriglyceridemia and impaired fatty acid incorporation into adipose tissue glycerides (FIAT) both corrected by nicotinic acid. Acta Med Scand 1973; 194: 363–9
   PubMedGoogle Scholar
• Reaven G M. Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dys-lipidemia, and coronary heart disease. Am Heart J 1991; 121: 1283–8
   PubMed Web of Science ®Google Scholar
• Beaumont J-L, Carlson L A, Cooper G R, Pfeiffer Z, Fredrickson D S, Strasser T. Classification of hyperlipidaemias and hyperlipoproteinemias. Bull WHO 1970; 43: 891–915
   PubMed Web of Science ®Google Scholar
• Fletcher M J. A calorimetric method for estimating serum triglycerides. Clin Chim Acta 1968; 22: 393–7
   PubMed Web of Science ®Google Scholar
• Zlatkis A, Zak B, Boyle J. A new method for direct determination of serum cholesterol. J Lab Clin Med 1953; 41: 486–92
   PubMed Web of Science ®Google Scholar
• Carlson K. Lipoprotein fractionation. J Clin Path 1973; 26: 32–7, (Suppl 5)
   PubMed Web of Science ®Google Scholar
• Dole V PJ. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest 1956; 35: 150–4
   PubMed Web of Science ®Google Scholar
• Ho R J. Radiochemical assay of long-chain fatty acids using 63Ni as tracer. Anal Biochem 1970; 36: 105–13
   PubMed Web of Science ®Google Scholar
• Chernik S S. Determination of glycerol in acylglycerol. Methods of Enzymology XIV, SP Colowick, NO Kaplan. Academic Press, New York 1969; 627–30
   Google Scholar
• Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24–7
   Google Scholar
• Ikkos D, Luft R. On the intravenous glucose tolerance test. Acta Endocrinol (Copenh) 1957; 25: 312–34
   PubMedGoogle Scholar
• Walldius G, Rubba P. A micro-method for determination of fatty acid (FIAT) and glucose (GLIAT) incorporation and lipolysis in vitro in needle biopsies of human adipose tissue. Scand J Clin Lab Invest 1976; 36: 357–69
   PubMed Web of Science ®Google Scholar
• Walldius G. Fatty acid incorporation into human adipose tissue (FIAT) in hypertriglyceridemia. Methodological, clinical and experimental studies. Acta Med Scand 1976, Suppl 591
   PubMedGoogle Scholar
• Snedecor G W, Cochran W G. Statistical Methods, 7th ed. The Iowa State University Press, Ames, IowaUSA 1980
   Google Scholar
• Oldham P D. Measurements in medicine: The interpretation of numerical data. English University Press, London 1968; 148–52
   Google Scholar
• Schafrir E, Orevi M, Gutman A. Effect of nicotinic acid on carbohydrate metabolism in adipose tissue. Metabolic effects of nicotinic acid and its derivatives, KF Gey, LA Carlson. Hans Huber, Bern 1971; 763–71
   Google Scholar
• Lee H M, Ellis R M, Sigal M V, Jr. Some insulin-like effects of nicotinic acid observed with isolated rat epididymal adipose tissue. Biochim Biophys Acta 1961; 49: 408–10
   PubMedGoogle Scholar
• Björntorp P. Inhibition of lipase activation in rat epididymal fat pads in vitro. Am J Physiol 1966; 210: 733–6
   PubMedGoogle Scholar
• Ho R J, Jeanrenaud B. Insulin-like action of ouabain I. Effect on carbohydrate metabolism. Biochim Biophys Acta 1967; 144: 61–73
   PubMedGoogle Scholar
• Fröberg S, Boberg J, Carlson L A, Eriksson M. Effect of nicotinic acid on the diurnal variation of plasma levels of glucose, free fatty acids, triglycerides and cholesterol and of urinary excretion of catecholamines. Metabolic effects of nicotinic acid and its derivatives, KF Gey, LA Carlson. Hans Huber, Bern 1971; 167–81
   Google Scholar
• Carlson L A. Nicotinic acid: its metabolism and its effects on plasma free fatty acids. Metabolic effects of nicotinic acid and its derivatives, KF Gey, LA Carlson. Hans Huber, Bern 1971; 158–65
   Google Scholar
• Randle P J, Garland P B, Hales C N, Newsholme E A. The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785–9
   Google Scholar
• Ammon H PT, Estler C-J, Heim F. Alteration of carbohydrate metabolism in live, skeletal muscle and brain by nicotinic acid in mice. Metabolic effects of nicotinic acid and its derivaties, KF Gey, LA Carlson. Hans Huber, Bern 1971; 799–809
   Google Scholar
• Root M A, Ashmore J. The hypoglycemic activity of nicotinic acid in rats. Naunyn-Schmiedebergs Arch Exp Path Pharmak 1964; 248: 117–23
   PubMedGoogle Scholar
• Benito M, Moreno F J, Medina J M, Mayor F. Operation of the glucose-fatty acid cycle after glycogenolysis induced by treatment with nicotinic acid. Arch Biochem Biophys 1978; 188: 21–5
   PubMed Web of Science ®Google Scholar
• Balasse E O, Neef M A. Influence of nicotinic acid on the rates of turnover and oxidation of plasma glucose in man. Metabolism 1973; 22: 1193–1204
   PubMed Web of Science ®Google Scholar
• Hasselblatt A, Panten U, Poser W. Effects of antilipolytic compounds on hepatic and renal gluconeogenesis in the rat. Metabolic effects of nicotinic acid and its derivatives, KF Gey, LA Carlson. Hans Huber, Bern 1971; 879–84
   Google Scholar
• Wahlberg G, Carlson L A, Wasserman J, Ljungqvist A. Protective effect of nicotinamide against nephropathy in diabetic rats. Diabetes Res 1985; 2: 307–12
   PubMedGoogle Scholar
• Lassers B W, Wahlqvist M L, Kaijser L, Carlson L A. Relationship in man between plasma free fatty acids and myocardial metabolism of carbohydrate substrates. Lancet 1971; ii: 448–50
   Google Scholar
• Kaijser L, Nye E R, Eklund B, Olsson A G, Carlson L A. The relation between carbohydrate extraction by the forearm and arterial free fatty acid concentration in man. Scan J Clin Lab Invest 1978; 38: 41–7
   PubMed Web of Science ®Google Scholar
• Kahn S E, Beard J C, Schwartz M W. Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 1989; 38: 562–8
   PubMed Web of Science ®Google Scholar
• Kudchotkar B J, Sodhi H S, Horlick L, Mason D T. Mechanisms of hypolipidemic action of nicotinic acid. Clin Pharm Ther 1978; 24: 354–73
   PubMed Web of Science ®Google Scholar
• Mc Grundy S M, Mok H YI, Zech L, Herman M. Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res 1981; 22: 24–36
   PubMed Web of Science ®Google Scholar
• Carlson L A, Rosenhamer G. Reduction of mortality in the Stockholm ischaemic heart disese secondary prevention study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand 1988; 223: 405–18
   PubMed Web of Science ®Google Scholar
• Blankenhorn D H, Nessim S A, Johnson R L, Sanmarco M E, Azen S P, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233–40
   PubMed Web of Science ®Google Scholar
• Canner P L, Berge K G, Wenger N K. Fifteen year mortality in coronary drug patients: Long-term benefit with niacin. J Am Coll Cardiol 1986; 8: 1245–55
   PubMed Web of Science ®Google Scholar
• Stout R W. Blood glucose and atherosclerosis. Arteriosclerosis 1981; 1: 227–34
   PubMedGoogle Scholar
• Jarrett R J, McCartney P, Keen H. The Bedford Survey: Ten year mortality rates in newly diagnosed diabetics borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79–84
   PubMed Web of Science ®Google Scholar